Evidence map›Paper›PMID 42613329›Full record

ArticleNature communications2026

The metabokine β-aminoisobutyric acid mediates exercise performance and skeletal muscle adaptation through a PGC1α-BAIBA-PPARδ axis.

Helene N Daou, Nicole T Watt, Shaimaa A Gad, Amanda Dv MacCannell, Aysha Ali, Chew Cheng, Raquel L Fernando, T Simon Futers, Sumeet A Khetarpal, Harrison Gallagher and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Helene N DaouLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0001-6187-7955
Nicole T WattLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Shaimaa A GadLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-7506-5314
Amanda Dv MacCannellLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Aysha AliLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Chew ChengLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-2873-0828
Raquel L FernandoLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-7020-2463
T Simon FutersLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0003-3810-190X
Sumeet A KhetarpalDana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
Harrison GallagherFaculty of Biological Sciences, University of Leeds, Leeds, UK.
Luis D ChinaitInstitute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.ORCID http://orcid.org/0000-0001-6168-6518
Anselmo S MoriscotInstitute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.
Pim KnuimanDivision of Human Nutrition, Wageningen University and Research, Wageningen, Netherlands.
Koen ManusamaDivision of Human Nutrition, Wageningen University and Research, Wageningen, Netherlands.
Marco MensinkDivision of Human Nutrition, Wageningen University and Research, Wageningen, Netherlands.
Irvin TehLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Jurgen E SchneiderLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Richard CubbonLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0001-7844-3600
Guy S TaylorHuman Nutrition & Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Daniel J WestHuman Nutrition & Exercise Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
David J BeechLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-7683-9422
T Scott BowenFaculty of Biological Sciences, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-1740-2474
Lee D RobertsLeeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK. L.D.Roberts@leeds.ac.uk.ORCID http://orcid.org/0000-0002-1455-5248

Funding

Discovery of Heart-Derived Myokines Mediating the Response to Exercise Stress Via PGC-1aK08HL177169 · NHLBI · UNIVERSITY OF VIRGINIA · PI Sumeet Khetarpal · 2025 to 2026
$286k
Diabetes UK 16/0005382Diabetes UK 19/0006049NHLBI NIH HHS K08 HL177169RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/T004231/1
6 · The paper itself

Abstract

Exercise orchestrates an interorgan communication network, in which skeletal muscle releases signaling molecules known as myokines that contribute to exercise training-induced adaptations. We identified the muscle-derived metabolite beta-aminoisobutyric acid (BAIBA) as a regulator of adipose and hepatic metabolic responses to exercise. Here, we demonstrate that BAIBA regulates muscle metabolism, morphology and function via peroxisome proliferator-activated receptor delta (PPARδ) to determine exercise performance in mice. BAIBA mitigates muscle dysfunction in a mouse model of diabetes. Physiologically, BAIBA exists as D- and L- enantiomers. We identify L-BAIBA as the primary mediator of muscular effects. Knockdown of L-BAIBA's biosynthetic enzyme, 4-aminobutyrate aminotransferase, in mouse hindlimb muscle impairs exercise-induced adaptations and performance gains. L-BAIBA regulates human myotube fibertype and differentiation markers through Mas-related G-protein coupled receptor D. In humans, plasma L-BAIBA correlates with aerobic fitness and increases with endurance exercise training. BAIBA acts through the PGC1α-BAIBA-PPARδ axis to facilitate muscle adaptation and exercise performance.

Indexed as

Adaptation, PhysiologicalAminoisobutyric AcidsMuscle, SkeletalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhysical Conditioning, AnimalPPAR deltaAnimalsHumansMaleMiceMice, Inbred C57BLMuscle Fibers, SkeletalMyokinesSignal Transduction3-aminoisobutyric acidAminoisobutyric AcidsMyokinesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPAR deltaPpargc1a protein, mouse

Identifiers

PMID42613329
PMCPMC13487176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.